Hamill John P. 4
4 · Aprea Therapeutics, Inc. · Filed Jan 30, 2023
Insider Transaction Report
Form 4
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-01-30+539,758→ 539,758 totalExercise: $0.50Exp: 2033-01-30→ Common Stock (539,758 underlying) - Award
Common Stock
2023-01-30+269,879→ 269,879 total
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on January 30, 2023, and which will vest and be settled in common stock in three equal, annual installments beginning on January 30, 2024, January 30, 2025, and January 30, 2026, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.
- [F2]Twenty-five percent of these options vest on January 30, 2024, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.